|

225Ac-PSMA-Trillium (BAY3563254) Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Bayer1

Indications

  • Prostate Specific Membrane Antigen (PSMA) Expression1
  • Advanced Metastatic Castration-resistant Prostate Cancer1
  • Cancer1

Duarte, California1 trial

First-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)

City of Hope - Duarte Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.